Pay in 4 interest-free payments of $6.46 Learn more
Ships within 48 hours · Estimated delivery Aug 20 - Aug 25
Clinical data, including body composition analysis from the SURMOUNT-1 trial, confirms that tirzepatide produces reductions in both total body fat and visceral (abdominal) fat, the type most closely associated with metabolic health risks
But of the 13 consensus ratings of the companies in its portfolio, 11 assign the ETF a Buy or Moderate Buy rating, while just two assign it a Hold, and none rate it a Sell
In fact, many of the top search results for terms like Ozempic butt come from cosmetic surgery clinics that frame it as a purely aesthetic issuesomething they can fix with lifts, tucks, and fillers
None of this means total abstinence is required
Table 3 provides a summary of key dosing and administration information for currently marketed GLP-1 RAs
Targeting Visceral Fat Visceral fat wraps around internal organs and presents greater health risks than subcutaneous fat
